A recent study found that 1 in 5 households were strapped with medical debt; hospitals and hospital systems in North Carolina proposed a way to expand Medicaid to hundreds of thousands of adults; the CDC reported that more adults sought mental health treatment in 2021 compared with 2019.
Read More
Recommendations to Increase Equitable Psychosocial Outcomes for Children and Adolescents
September 18th 2022Nearly 30% of youths are affected with worsening mental health by the end of adolescence, with anxiety typically presenting in childhood and depression during the teenage years, but the problem is even more acute for Black and Latinx youth.
Read More
Contributor: Improving Utilization Management Can Better Outcomes, Cut Costs in Cardiovascular Care
September 18th 2022Russell Rotondo, MD, FACC, medical director of clinical strategy and innovation for cardiology at Cohere Health, discusses the myriad positive ways utilization management programs can have an impact on patient outcomes in cardiovascular care.
Read More
Review Highlights Advances in SCD Treatment, Potential Targets for Novel Agents
September 17th 2022The review discusses hydroxyurea and 3 additional drugs approved by the FDA—L-glutamine, crizanlizumab, and voxelotor—as well as agents currently being investigated to treat sickle cell disease (SCD).
Read More
Dr Patrick Burnett on Shared Decision-Making for Moderate to Severe Psoriasis
September 17th 2022Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discusses clinical recommendations for patients with moderate to severe psoriasis, particularly the need for shared decision-making.
Watch
ICER Releases Draft Evidence Report on Gene Therapies for Hemophilia A and B
September 17th 2022Despite $2.5 million placeholder price tags, the Institute for Clinical and Economic Review draft evidence report considers gene therapy cost-effective versus comparators in both hemophilia A and B.
Read More
Potential for Precision Medicine Approach in PAH Explored in New Study
September 16th 2022This new study of pulmonary arterial hypertension (PAH) among women examined the in-common symptoms of different disease phenotypes to see where they overlap and ultimately to define the “symptome” according to symptom cluster and characteristics.
Read More
Optimizing Emergency Care Processes Improves Outcomes for Hospitalized Patients With HE
September 16th 2022Patients with hepatic encephalopathy (HE) often do not seek care until they are in critical condition, making an optimized emergency care process critical to reduce adverse prognosis and improve clinical symptoms.
Read More
Multitask Learning Model Outperforms Traditional Machine Learning Models in RCTs, Developers Say
September 16th 2022The proposed multitask learning (MTL) model was developed using data from wearable devices worn by individuals in a randomized controlled trial (RCT) to predict outcomes of a depression treatment.
Read More
Pramipexole, Citalopram Effective Therapies for Depression in Parkinson Disease
September 16th 2022Patients with Parkinson disease demonstrated significant reduction in depressive symptoms with citalopram and pramipexole, with pramipexole showing slightly more benefit in improving quality of life.
Read More
Sustained Glucose Control Does Not Slow Decline of C-Peptide in Randomized T1D Study
September 16th 2022This randomized, multicenter study of children and adolescents with new-onset type 1 diabetes (T1D) investigated the effect on glucose control of a closed-loop system, using C-peptide levels to gauge response
Read More
Improved CPMs Needed for Guiding Methotrexate Use in RA
September 16th 2022The study analyzed 20 clinical prediction models (CPMs) for rheumatoid arthritis (RA), all of which were deemed to have a high risk of bias, leading the researchers to urge against their use to guide decision-making without addressing their limitations.
Read More
Health experts warn that all should brace for a flu season that could be worse than the past 2 years; the CDC is opening applications to a vaccine equity program that will help those who may have limited access to the monkeypox vaccine; a new report found that health care services will be greatly affected by climate change.
Read More
Advocate Details Challenges Faced in Path to Diagnosis for Hidradenitis Suppurativa
September 16th 2022Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected by hidradenitis suppurativa (HS), discussed the misconceptions she faced from clinicians regarding her clinical symptoms of HS prior to diagnosis.
Watch
More Diversity, Multifaceted Outreach Needed in Studies of Genetic Screening for Depression
September 15th 2022Three types of salient beliefs were investigated in this study that examined why mothers would or would not participate in depression screening via genetic salivary testing, with the results indicating potential for mental health disparities among diverse populations.
Read More
AHCL Insulin Delivery Linked to Better QOL, Metabolic Control in Children With T1D
September 15th 2022Children and adolescents with type 1 diabetes (T1D) saw improved quality of life (QOL) and metabolic control when using an advanced hybrid closed-loop (AHCL) insulin delivery method vs conventional therapy.
Read More
Researchers Evaluate Racism as a Factor in Underestimation of Atopic Disease
September 15th 2022Although allergic and atopic disease is well studied and researched overall, the researchers said there is a critical lack of knowledge about these conditions, including eosinophilic esophagitis, asthma, and atopic dermatitis, in diverse racial and ethnic groups.
Read More
Digital Medication Monitor Linked to Better HRQOL, Lower Costs for Tuberculosis
September 15th 2022Patients with tuberculosis who used a digital medication reminder monitor had better health-related quality of life (HRQOL) and lower catastrophic costs compared with patients who used a standard therapy.
Read More
The House passed a bill that would streamline prior authorization requirements under Medicare Advantage (MA) plans; last week had the fewest COVID-19 deaths reported globally since March 2020; older Americans who survived COVID-19 had a 69% higher risk of developing Alzheimer disease compared with their uninfected counterparts.
Read More